托法替布与依那西普心血管、癌症及带状疱疹风险的比较：单中心观察性研究 - Suppr

Comparison of cardiovascular, cancer and herpes zoster risk of tofacitinib versus etanercept: single-centre observational study.

作者信息

Bilgin Emre, Duran Emine, Ünaldı Erdinç, Kalyoncu Umut, Kiraz Sedat, Ertenli İhsan

机构信息

Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara, Turkey.

出版信息

Rheumatology (Oxford). 2022 Aug 30;61(9):e267-e269. doi: 10.1093/rheumatology/keac226.

DOI:10.1093/rheumatology/keac226

PMID:35394013

Abstract

摘要

相似文献

Comparison of cardiovascular, cancer and herpes zoster risk of tofacitinib versus etanercept: single-centre observational study.

Rheumatology (Oxford). 2022 Aug 30;61(9):e267-e269. doi: 10.1093/rheumatology/keac226.

Using Number Needed to Harm to Put the Risk of Herpes Zoster From Tofacitinib in Perspective.

Inflamm Bowel Dis. 2019 May 4;25(6):955-957. doi: 10.1093/ibd/izy387.

Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib.

Inflamm Bowel Dis. 2018 Sep 15;24(10):2258-2265. doi: 10.1093/ibd/izy131.

Live Zoster Vaccine in Patients With Rheumatoid Arthritis Treated With Tofacitinib With or Without Methotrexate, or Adalimumab With Methotrexate: A Post Hoc Analysis of Data From a Phase IIIb/IV Randomized Study.

Arthritis Care Res (Hoboken). 2020 Mar;72(3):353-359. doi: 10.1002/acr.24010.

Herpes Zoster in Patients Receiving JAK Inhibitors For Ulcerative Colitis: Mechanism, Epidemiology, Management, and Prevention.

Inflamm Bowel Dis. 2018 Sep 15;24(10):2173-2182. doi: 10.1093/ibd/izy150.

Real-world comparative risks of herpes virus infections in tofacitinib and biologic-treated patients with rheumatoid arthritis.

Ann Rheum Dis. 2016 Oct;75(10):1843-7. doi: 10.1136/annrheumdis-2016-209131. Epub 2016 Apr 25.

Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials.

Ann Rheum Dis. 2017 Jul;76(7):1253-1262. doi: 10.1136/annrheumdis-2016-210457. Epub 2017 Jan 31.

Risk for Herpes Zoster in Tofacitinib-Treated Rheumatoid Arthritis Patients With and Without Concomitant Methotrexate and Glucocorticoids.

Arthritis Care Res (Hoboken). 2019 Sep;71(9):1249-1254. doi: 10.1002/acr.23769. Epub 2019 Jul 29.

Herpes zoster and tofacitinib therapy in patients with rheumatoid arthritis.

Arthritis Rheumatol. 2014 Oct;66(10):2675-84. doi: 10.1002/art.38745.

Herpes zoster as a cause of atypical chronic ulcerations associated with tofacitinib.

Dermatol Online J. 2018 Jan 15;24(1):13030/qt3v77g2zg.

引用本文的文献

Comparative Safety of JAK Inhibitors vs TNF Antagonists in Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-Analysis.

JAMA Netw Open. 2025 Sep 2;8(9):e2531204. doi: 10.1001/jamanetworkopen.2025.31204.

Comparative Cancer Incidence by Organ Site in Rheumatoid Arthritis Treated with Janus Kinase Inhibitors versus Tumor Necrosis Factor Inhibitors: A Retrospective Real-World Cohort Analysis.

Biologics. 2025 Aug 30;19:525-538. doi: 10.2147/BTT.S532668. eCollection 2025.

How to Use Janus Kinase Inhibitors in the Treatment of Rheumatoid Arthritis? A Clinical Assessment of Risks and Benefits.

Curr Rheumatol Rep. 2023 Dec;25(12):295-306. doi: 10.1007/s11926-023-01122-9. Epub 2023 Dec 16.

Managing Cardiovascular and Cancer Risk Associated with JAK Inhibitors.

Drug Saf. 2023 Nov;46(11):1049-1071. doi: 10.1007/s40264-023-01333-0. Epub 2023 Jul 25.

Cardiovascular Disease Risk in Rheumatoid Arthritis Anno 2022.

J Clin Med. 2022 May 11;11(10):2704. doi: 10.3390/jcm11102704.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Comparison of cardiovascular, cancer and herpes zoster risk of tofacitinib versus etanercept: single-centre observational study.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Comparison of cardiovascular, cancer and herpes zoster risk of tofacitinib versus etanercept: single-centre observational study.

作者信息

机构信息

出版信息

相似文献

引用本文的文献